How Life Sciences Companies Can Create Real Impact With Patient Engagement

A “maturity curve” can help organizations move their patient engagement activities beyond performative gestures to a strategic asset. This article, published in Pharmaceutical Executive in September 2026, was written by Noël Theodosiou, Principal & CEO and Amy Dorgan, Head of Consulting & Solutions, in collaboration with Donna Cryer, leading patient advocate and Co-Founder, Cryer Health.